SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-94586"
 

Search: onr:"swepub:oai:DiVA.org:umu-94586" > Negative mood chang...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Negative mood changes during hormone replacement therapy : a comparison between two progestogens

Björn, Inger, 1953- (author)
Umeå universitet,Obstetrik och gynekologi
Bixo, Marie, 1957- (author)
Umeå universitet,Obstetrik och gynekologi
Strandberg Nöjd, Karin (author)
Umeå universitet,Obstetrik och gynekologi
show more...
Nyberg, Sigrid (author)
Umeå universitet,Obstetrik och gynekologi
Bäckström, Torbjörn, 1948- (author)
Umeå universitet,Obstetrik och gynekologi
show less...
 (creator_code:org_t)
Elsevier, 2000
2000
English.
In: American Journal of Obstetrics and Gynecology. - : Elsevier. - 0002-9378 .- 1097-6868. ; 183:6, s. 1419-1426
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective: The aim of this study was to compare side effects of medroxyprogesterone acetate and norethindrone acetate during postmenopausal hormone replacement therapy in women with and without a history of premenstrual syndrome. Study Design: Fifty-one postmenopausal women were randomly selected in a double-blind crossover study. The women received 2 mg of estradiol continuously during five 28-day cycles and 10 mg of medroxyprogesterone or 1 mg of norethindrone sequentially for 12 days of each cycle. Daily symptom rating scales were kept. Results: The women showed cyclic changes, with negative mood and physical symptoms culminating during the late progestogen phase and positive mood during the estrogen-only phase. Symptoms declined with time but remained after 5 months. Women with a history of premenstrual syndrome responded strongly to both progestogens. Medroxyprogesterone acetate induced less negative and more positive mood symptoms than norethindrone in women with no history of premenstrual syndrome. In both groups medroxyprogesterone caused more physical symptoms than norethindrone. Conclusion: The addition of medroxyprogesterone to estrogen is preferable to norethindrone with respect to mood symptoms in women without a history of premenstrual syndrome.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)

Keyword

Hormone replacement therapy
progestogen
mood
negative side effects
adverse effects

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view